Halozyme Therapeutics Inc
Closed
SectorHealthcare
76.25 -2.89
Overview
Share price change
24h
Min
75.39
Max
76.39
Income | 292M 150M |
|---|---|
Sales | -75M 377M |
P/E Sector Avg | 28.344 60.549 |
EPS | 1.221 |
Profit margin | 39.832 |
Employees | 423 |
EBITDA | -62M 220M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +6.3% upside |
Next Earnings | 4 Aug 2026 |
|---|
Market Cap | 1.9B 9.6B |
|---|---|
Previous open | 79.14 |
Previous close | 76.25 |
News Sentiment
By Acuity
77%
23%
319 / 342 Healthcare
Halozyme Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Halozyme Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 81 USD 6.3%
High 96 USD
Low 57 USD
Based on 6 Wall Street analysts offering 12 month price targets forHalozyme Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$